Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Affymetrix Inc Issues Q1 2013 Revenue Guidance Below Analysts' Estimates


Tuesday, 9 Apr 2013 06:00am EDT 

Affymetrix Inc announced that it expects total revenue of approximately $78 million for the first quarter of 2013, including revenue of approximately $19 million from eBioscience. Revenues for the first quarter were below expectations, primarily due to continued headwinds in gene expression business across all regions, in particular Japan. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $83 million for the first quarter of 2013. 

Company Quote

9.635
0.215 +2.28%
18 Dec 2014